Haemonetics (HAE) Current Assets (2010 - 2026)

Haemonetics' Current Assets history runs 17 years deep, the most recent figure standing at $834.9 million for Q1 2026.

• In Q1 2026, Current Assets fell 10.71% year-over-year to $834.9 million; the TTM figure through Mar 2026 stood at $834.9 million (down 10.71% YoY), while the FY2026 annual figure was $834.9 million, down 10.71% from the prior year.
• Current Assets was $834.9 million for Q1 2026 at Haemonetics, down from $943.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.0 billion in Q4 2024 to a low of $687.8 million in Q3 2022.
• Historically, Current Assets has averaged $835.2 million across 5 years, with a median of $818.2 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Current Assets soared 31.49% in 2024, then declined 10.71% in 2026.
• A 5-year view of Current Assets shows it stood at $706.3 million in 2022, then rose by 8.31% to $765.0 million in 2023, then soared by 31.49% to $1.0 billion in 2024, then dropped by 6.18% to $943.7 million in 2025, then declined by 11.53% to $834.9 million in 2026.
• The last three Current Assets figures came in at $834.9 million (Q1 2026), $943.7 million (Q4 2025), and $899.7 million (Q3 2025), per Business Quant data.